Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.3 ILa | +6.19% | +10.95% | -30.09% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 14.45 | 67.11 | 26.87 | 21.6 | 15.51 | - | - |
Enterprise Value (EV) 1 | 14.45 | 67.11 | 26.87 | 21.6 | 15.51 | 15.51 | 15.51 |
P/E ratio | -2.46 x | - | - | - | - | - | - |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | - | 67.1 x | - | - | - | - | 2.01 x |
EV / Revenue | - | 67.1 x | - | - | - | - | 2.01 x |
EV / EBITDA | - | - | - | - | - | - | - |
EV / FCF | - | - | -1.6 x | -1.08 x | -1.94 x | -0.97 x | -0.65 x |
FCF Yield | - | - | -62.4% | -92.3% | -51.6% | -103% | -155% |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 19,561 | 172,106 | 184,277 | 244,589 | 261,132 | - | - |
Reference price 2 | 0.7389 | 0.3899 | 0.1458 | 0.0883 | 0.0594 | 0.0594 | 0.0594 |
Announcement Date | 2/11/20 | 3/2/21 | 2/8/23 | 3/5/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | 1 | - | - | - | - | - | 7.7 |
EBITDA | - | - | - | - | - | - | - | - |
EBIT 1 | - | -12.61 | - | -22.6 | -22.27 | -18 | -25.2 | -33.1 |
Operating Margin | - | -1,261.2% | - | - | - | - | - | -429.87% |
Earnings before Tax (EBT) 1 | - | - | -17.83 | - | - | -13 | - | - |
Net income 1 | -5.85 | -28 | -18.38 | - | - | -13 | - | - |
Net margin | - | -2,799.9% | - | - | - | - | - | - |
EPS | -0.3000 | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | -16.76 | -19.93 | -8 | -16 | -24 |
FCF margin | - | - | - | - | - | - | - | -311.69% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 2/11/20 | 3/2/21 | 2/9/22 | 2/8/23 | 3/5/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | - | -5.081 | -6.601 | -5.122 | -5.135 | -5.747 | -6.267 | -5.2 | -4.7 | -4.3 | -3.9 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - |
Net income | -10.83 | - | - | - | - | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - |
EPS | -0.0600 | - | - | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 8/4/22 | 11/8/22 | 2/8/23 | 5/16/23 | 8/22/23 | 11/21/23 | 3/5/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | -16.8 | -19.9 | -8 | -16 | -24 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | - | - | 0.03 | 0 | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 2/11/20 | 3/2/21 | 2/9/22 | 2/8/23 | 3/5/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.09% | 15.51M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+2.13% | 22.25B | |
-14.77% | 21.68B | |
-8.79% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- PPBT Stock
- Financials Purple Biotech Ltd